Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased – and that’s in some doubt, according to experts contacted by CBD-Intel.
The details of regulation are likely to depend on the type of cannabinoid product, the source, how the product will be used, potency and drug-to-drug interactions.
Former FDA commissioner Scott Gottlieb said it could take two to three years, before stepping down earlier this month. That now appears to be a best case scenario.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.